RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 122 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $310,000 | +84.5% | 84,600 | +11.9% | 0.02% | +56.2% |
| Q2 2016 | $168,000 | -74.6% | 75,600 | -76.3% | 0.02% | -76.1% |
| Q1 2016 | $662,000 | -31.4% | 318,700 | 0.0% | 0.07% | -45.5% |
| Q4 2015 | $965,000 | +25.7% | 318,700 | +2.0% | 0.12% | +23.0% |
| Q3 2015 | $768,000 | +46.3% | 312,500 | +90.8% | 0.10% | +37.0% |
| Q2 2015 | $525,000 | -10.1% | 163,800 | 0.0% | 0.07% | -11.0% |
| Q1 2015 | $584,000 | +889.8% | 163,800 | +525.2% | 0.08% | +720.0% |
| Q4 2014 | $59,000 | – | 26,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |